Poaty-Mavoungou Virginie, Touré Fousseyni S, Tevi-Benissan Carol, Mavoungou Elie
Centre International de Recherches Médicales de Franceville, Gabon.
Viral Immunol. 2002;15(1):197-212. doi: 10.1089/088282402317340341.
We studied the innate immune system of Cynomolgus monkeys (Macaca fascicularis) experimentally infected via the vaginal mucosae with a virulent simian immunodeficiency virus isolate SIVmac251. Animals were evaluated for their natural killer (NK) cell activity, and for their antibody-dependent cellular cytotoxicity. NK cells from SIVmac251-infected macaques show impaired NK cell activity compared to cells from uninfected animals. Subsequent treatment of NK cells with interferon-a (IFN-alpha) or interleukin-12 (IL-12) alone partially restored the NK activity. However, either treatment of NK cells with both IFN-alpha and IL-12 completely reversed the impairment of cytotoxicity induced by simian immunodeficiency virus (SIV) infection. Incubation of NK cells from infected but not from uninfected monkeys with IFN-alpha and IL-12 for 8 days increased the percentage of CD16+/CD56+ cells twofold to five-fold and enhanced antibody-dependent cellular cytotoxicity (ADCC) activity. Thus IFN-alpha and IL-12 greatly enhance both the NK cell and ADCC activities of peripheral blood cells from SIVmac251-infected animals and increase the number of NK cells in longer term culture. The combined effect of IFN-alpha and IL-12 in enhancing NK cell activity may provide a novel therapeutic approach for the restoration of depressed NK cell activity observed in human immunodeficiency virus (HIV)-infected patients.
我们研究了通过阴道黏膜经实验感染毒性猿猴免疫缺陷病毒分离株SIVmac251的食蟹猴(猕猴)的先天免疫系统。对动物的自然杀伤(NK)细胞活性及其抗体依赖性细胞毒性进行了评估。与未感染动物的细胞相比,来自SIVmac251感染猕猴的NK细胞显示出NK细胞活性受损。随后单独用干扰素-α(IFN-α)或白细胞介素-12(IL-12)处理NK细胞可部分恢复NK活性。然而,用IFN-α和IL-12同时处理NK细胞可完全逆转猿猴免疫缺陷病毒(SIV)感染诱导的细胞毒性损伤。将感染但未感染的猴子的NK细胞与IFN-α和IL-12一起孵育8天,可使CD16 + / CD56 +细胞的百分比增加两倍至五倍,并增强抗体依赖性细胞毒性(ADCC)活性。因此,IFN-α和IL-12极大地增强了来自SIVmac251感染动物的外周血细胞的NK细胞和ADCC活性,并在长期培养中增加了NK细胞的数量。IFN-α和IL-12在增强NK细胞活性方面的联合作用可能为恢复在人类免疫缺陷病毒(HIV)感染患者中观察到的NK细胞活性降低提供一种新的治疗方法。